Progressive decline of glucocerebrosidase in aging and Parkinson's disease

The principal risk factor for developing most adult onset neurodegenerative diseases is aging, with incidence rising significantly after age 50. Despite research efforts, the causes of Parkinson's disease (PD) remain unknown. As neurons age, they show signs of diminished lysosomal and mitochondrial function, including increased oxidative stress and accumulation of misfolded proteins, and these changes become exacerbated PD. We show that activity of the lysosomal hydrolase glucocerebrosidase gradually diminishes with age in the substantia nigra and putamen of healthy controls. This reduction is comparable to glucocerebrosidase activity in GBA1‐mutation carrier PD patients. These data, demonstrate for the first time that an age‐dependent reduction in glucocerebrosidase activity may lower the threshold for developing PD.

[1]  Houeto Jean-Luc.  [Parkinson's disease]. , 2022, La Revue du praticien.

[2]  D. Berg,et al.  GBA‐associated Parkinson's disease: Reduced survival and more rapid progression in a prospective longitudinal study , 2015, Movement disorders : official journal of the Movement Disorder Society.

[3]  I. Guella,et al.  Glucocerebrosidase mutations in primary parkinsonism , 2014, Parkinsonism & related disorders.

[4]  G. Halliday,et al.  Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson's disease. , 2014, Brain : a journal of neurology.

[5]  W. Westbroek,et al.  Glucocerebrosidase is shaking up the synucleinopathies. , 2014, Brain : a journal of neurology.

[6]  Ellen Sidransky,et al.  The link between the GBA gene and parkinsonism , 2012, The Lancet Neurology.

[7]  J. Hardy,et al.  Glucocerebrosidase Deficiency in Substantia Nigra of Parkinson Disease Brains , 2012, Annals of neurology.

[8]  Ying Sun,et al.  Gaucher Disease Glucocerebrosidase and α-Synuclein Form a Bidirectional Pathogenic Loop in Synucleinopathies , 2011, Cell.

[9]  A. Singleton,et al.  Complete screening for glucocerebrosidase mutations in Parkinson disease patients from Portugal , 2009, Neurobiology of Aging.

[10]  Aj Lees,et al.  Parkinson's disease (vol 373, pg 2055, 2009) , 2009 .

[11]  A. Singleton,et al.  Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease. , 2009, Brain : a journal of neurology.

[12]  A. Singleton,et al.  Emerging pathways in genetic Parkinson's disease: Potential role of ceramide metabolism in Lewy body disease , 2008, The FEBS journal.

[13]  C. Chu,et al.  Beclin 1-Independent Pathway of Damage-Induced Mitophagy and Autophagic Stress: Implications for Neurodegeneration and Cell Death , 2007, Autophagy.

[14]  Daniel J. Klionsky,et al.  Autophagy: from phenomenology to molecular understanding in less than a decade , 2007, Nature Reviews Molecular Cell Biology.

[15]  K. Marder,et al.  Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease , 2007, Neurology.

[16]  Ana Maria Cuervo,et al.  Protein degradation and aging , 2005, Experimental Gerontology.

[17]  J. Trojanowski,et al.  Synucleinopathies: clinical and pathological implications. , 2001, Archives of neurology.

[18]  Katunina Ea,et al.  [Epidemiology of Parkinson's disease]. , 2013, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.

[19]  J. Stockman.  Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease , 2011 .